Metraipolis › archive › dc_0cff19c98657
Antibody-based therapeutics and therapeutic development for diabetic retinopathy: targeting VEGF, Ang/Tie, and inflammatory pathways — Europe PMC PMID:41601934
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41601934
- DOI
- 10.3389/fendo.2025.1710376
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T21:05:37.311Z
- SHA-256 of the archived text
5f065197ee2505a86fc9b136e8669f08dd42814ecb1d83b250cbedd39a7dd0ad- Stable URL of this page
https://metraipolis.com/documento/dc_0cff19c98657
How to cite
Antibody-based therapeutics and therapeutic development for diabetic retinopathy: targeting VEGF, Ang/Tie, and inflammatory pathways — Europe PMC PMID:41601934 — Europe PMC (en), https://europepmc.org/article/MED/41601934 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0cff19c98657 (Metraipolis archive dc_0cff19c98657, sha256 5f065197ee2505a86fc9b136e8669f08dd42814ecb1d83b250cbedd39a7dd0ad)
BibTeX
@misc{dc0cff19c98657,
title = {Antibody-based therapeutics and therapeutic development for diabetic retinopathy: targeting VEGF, Ang/Tie, and inflammatory pathways — Europe PMC PMID:41601934},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41601934},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0cff19c98657; sha256 5f065197ee2505a86fc9b136e8669f08dd42814ecb1d83b250cbedd39a7dd0ad},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601934. Agents can read the archived copy with the MCP tool read_document.